Phosplatin Therapeutics Appoints Lorenzo Galluzzi, PhD, a Pioneer in Immunogenic Cell Death Research, to Scientific Advisory Board

Press/Media

Period	Mar 24 2022

Media coverage

Title	Phosplatin Therapeutics Appoints Lorenzo Galluzzi, PhD, a Pioneer in Immunogenic Cell Death Research, to Scientific Advisory Board
Media name/outlet	Morningstar.com
Country/Territory	United States
Date	03/24/22
URL	https://www.morningstar.com/news/pr-newswire/20220324ny01980/phosplatin-therapeutics-appoints-lorenzo-galluzzi-phd-a-pioneer-in-immunogenic-cell-death-research-to-scientific-advisory-board
Persons	Lorenzo Galluzzi